Of note, one limitation resides in the fact that the study design does not allow discrimination whether these abnormalities directly result from the previous GH/IGF-I excess or develop as a long-term consequence of metabolic alterations due to glucose, lipids and adipocytokines, because no patients with active acromegaly were included in this study. Here, GH1 is linked to acromegaly.